If you are looking to buy ipamorelin no dac manchester or anywhere else in the UK, understanding the distinction between CJC-1295 variants is essential. The market offers two versions of CJC-1295—with DAC and without DAC—and the choice between them determines dosing frequency, GH pulse pattern, and ultimately, the suitability for your research protocol.
This guide explains the pharmacodynamic differences between CJC-1295 with and without DAC, clarifies why the no-DAC variant is the standard pairing partner for Ipamorelin, and provides a framework for sourcing research-grade peptides across UK labs.
Understanding the DAC Distinction
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It exists in two primary forms, differentiated by the presence of a Drug Affinity Complex (DAC) moiety.
The DAC Modification Explained
DAC = Drug Affinity Complex—a small protein domain that allows the peptide to bind covalently to albumin in the blood. Once bound to albumin, the peptide is protected from degradation and slowly releases over days.
The result is a dramatically extended half-life: CJC-1295 with DAC has a half-life of approximately 6–8 days, compared to roughly 30 minutes for the no-DAC version .
| Feature | CJC-1295 with DAC | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|---|
| Half-Life | ~6–8 days | ~30 minutes |
| Dosing Frequency | 1–2 injections per week | 1–3 injections per day |
| GH Pattern | Sustained, elevated baseline | Discrete, pulsatile spikes |
| Physiological Fidelity | Less natural | Mimics natural GH pulsatility |
Why No-DAC Is the Preferred Ipamorelin Partner
The no-DAC form is the standard pairing partner for Ipamorelin because their pulse timing matches. Both compounds have short half-lives (approximately 30 minutes to 2 hours), allowing their plasma peaks to align. When dosed together:
- CJC-1295 primes the pituitary, increasing the available GH pool
- Ipamorelin triggers the acute release of that pool
- The combined pulse is substantially larger than either compound alone
By contrast, the DAC form’s sustained activation does not coordinate with Ipamorelin’s short pulse in the same synergistic way . Most researchers either use no-DAC plus Ipamorelin or DAC alone.
📞 Need Help Sourcing Research Peptides?
Whether you are based in London, Cambridge, or Manchester, our team can assist with questions about purity verification and product specifications.
Quality Standards: What a COA Must Include
For research-grade peptide sourcing, always verify the Certificate of Analysis. A legitimate COA should include :
- HPLC purity analysis confirming ≥98% purity with a clear chromatogram
- Mass spectrometry (LC-MS) confirmation verifying the peptide sequence
- Confirmation of DAC modification (for DAC version) via high-resolution mass spectrometry
- Batch-specific traceability matching the vial label
- Endotoxin testing <0.25 EU via LAL assay
- Residual water content <8% for stable lyophilised product
- Certificate of Analysis dated and associated with the batch number
UK Supplier Landscape
Several UK-based suppliers offer CJC-1295 and Ipamorelin blends for research purposes:
- Genetra Research: UK-manufactured peptides with >99% purity
- Pepcore: CJC-1295 + Ipamorelin + Tesamorelin bundles with 99% HPLC purity
- Ascend Peptides UK: Laboratory research materials with purity verification
Common Buyer Scenarios
The Protocol-Specific Researcher: You require coordinated pulse timing for GH-axis research. The no-DAC variant paired with Ipamorelin provides matched half-lives for discrete, amplified pulses.
The Convenience-Focused Lab: You prefer less frequent dosing. The DAC variant requires only 1–2 injections per week.
The Quality-Focused Laboratory: You require ≥98% HPLC-verified purity. Look for suppliers who provide batch-specific COAs with independent analytical data.
Conclusion
The choice between CJC-1295 with DAC and without DAC depends on your research protocol requirements. The no-DAC variant, when paired with Ipamorelin, provides matched pharmacokinetics for discrete, pulsatile GH amplification that mimics physiological release patterns. The DAC variant offers convenience through sustained GH elevation but loses the pulsatile pattern that many researchers consider more physiologically relevant. Always source from suppliers who can provide batch-specific, third-party COA verification with HPLC purity analysis.
